ObjectivesChronic thromboembolic pulmonary hypertension is due to partial obstruction of the pulmonary arterial bed and may resolve after pulmonary thromboendarterectomy. Persistent pulmonary hypertension, the main complication after pulmonary thromboendarterectomy, may reflect vessel alterations induced by high flow in unobstructed lung territories. The aim of this study was to determine whether correcting high flow led to reversal of the vasculopathy in piglets.MethodsThe effects of high pulmonary blood flow were investigated 5 weeks after creation of an aortopulmonary shunt (n = 10), and reversibility of vessel disease was evaluated at 1 week (n = 10) and 5 weeks after shunt closure (n = 10), compared to sham-operated animals (n = 10). H...
• Widespread pulmonary arterial thrombosis is a well-known complication of severe pul-monic valvular...
AbstractObjective: A consistent pathologic feature seen in lungs of patients with pulmonary hyperten...
AbstractPulmonary arterial hypertension (PAH) has a multifactorial pathobiology. Vasoconstriction, r...
ObjectivesChronic thromboembolic pulmonary hypertension is due to partial obstruction of the pulmona...
ObjectivesIn patients with chronic thromboembolic pulmonary hypertension, high flow in unobstructed ...
AbstractObjectivesPulmonary vascular resistance decreases dramatically after pulmonary thromboendart...
ObjectiveThe study objective was to determine whether the vasculopathy seen in nonobstructed lung re...
AbstractObjectives: We characterized the morphology and vasomotor responses of a localized, high-flo...
AbstractThis study examined the hypothesis that chronic high pulmonary blood flow produces dysfuncti...
AbstractObjective: The 2 main causes of death after thromboendarterectomy for chronic pulmonary thro...
AbstractObjectiveCardiac surgery for congenital heart defects is commonly complicated by shunt-induc...
AbstractBackground: Children with increased pulmonary blood flow may experience morbidity as the res...
AbstractBackground: Endothelin-1 has been shown to be a mediator of pulmonary hypertension after car...
ObjectivesContinuous flow in the Fontan circulation results in impairment of pulmonary artery endoth...
BackgroundSurgical and catheter-based interventions on pulmonary veins are associated with pulmonary...
• Widespread pulmonary arterial thrombosis is a well-known complication of severe pul-monic valvular...
AbstractObjective: A consistent pathologic feature seen in lungs of patients with pulmonary hyperten...
AbstractPulmonary arterial hypertension (PAH) has a multifactorial pathobiology. Vasoconstriction, r...
ObjectivesChronic thromboembolic pulmonary hypertension is due to partial obstruction of the pulmona...
ObjectivesIn patients with chronic thromboembolic pulmonary hypertension, high flow in unobstructed ...
AbstractObjectivesPulmonary vascular resistance decreases dramatically after pulmonary thromboendart...
ObjectiveThe study objective was to determine whether the vasculopathy seen in nonobstructed lung re...
AbstractObjectives: We characterized the morphology and vasomotor responses of a localized, high-flo...
AbstractThis study examined the hypothesis that chronic high pulmonary blood flow produces dysfuncti...
AbstractObjective: The 2 main causes of death after thromboendarterectomy for chronic pulmonary thro...
AbstractObjectiveCardiac surgery for congenital heart defects is commonly complicated by shunt-induc...
AbstractBackground: Children with increased pulmonary blood flow may experience morbidity as the res...
AbstractBackground: Endothelin-1 has been shown to be a mediator of pulmonary hypertension after car...
ObjectivesContinuous flow in the Fontan circulation results in impairment of pulmonary artery endoth...
BackgroundSurgical and catheter-based interventions on pulmonary veins are associated with pulmonary...
• Widespread pulmonary arterial thrombosis is a well-known complication of severe pul-monic valvular...
AbstractObjective: A consistent pathologic feature seen in lungs of patients with pulmonary hyperten...
AbstractPulmonary arterial hypertension (PAH) has a multifactorial pathobiology. Vasoconstriction, r...